Categories: News

ProSomnus® Sleep Technologies to Present Three Posters at 2022 American Academy of Dental Sleep Medicine Annual Meeting

Company to showcase efficacy of its precision Oral Appliance Therapy devices in treating Obstructive Sleep Apnea

SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) — ProSomnus Sleep Technologies, the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that it will showcase its precision Oral Appliance Therapy (OAT) devices in three poster abstracts at the 2022 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, being held from May 13-15 in Dallas, Texas.

ProSomnus researchers will present the three abstracts simultaneously on Saturday, May 14 at 10:00am central time and again at 4:00pm.

Now in its 30th iteration, the AADSM Annual Meeting is attended by dentists, dental team members, physicians, scientists, and other health care professionals who treat or have an interest in treating patients with sleep-disordered breathing.

About ProSomnus Sleep Technologies
ProSomnus is the first manufacturer of precision, mass-customized Oral Appliance Therapy (OAT) devices to treat Obstructive Sleep Apnea (OSA), which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus’s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 135,000 patients treated, ProSomnus’s devices are the most prescribed OATs in the U.S. To learn more, visit www.ProSomnus.com.

Contacts

Media
Sean Leous
Sean.Leous@westwicke.com

Investors
Mike Cavanaugh
Mike.Cavanaugh@westwicke.com

Staff

Recent Posts

CorVel Announces Effectiveness of Three-For-One Forward Stock Split

FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced…

5 hours ago

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be…

5 hours ago

Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025

If you are male and in your 40's and 50's and feel your testosterone levels…

17 hours ago

The Anxiety Clinic Launches Innovative Approach to Transform Anxiety into Positive Energy

Transforming Anxiety into Positive Energy: A New Approach by The Anxiety ClinicBondi Junction, New South…

21 hours ago

Solace Psychology Announces Expanded Holiday Stress Management and Mental Health Support Services

Embracing Mental Well-Being During the Festive SeasonCarlton North, Australia--(Newsfile Corp. - December 24, 2024) -…

23 hours ago

Strong Natural Diet Pill Over the Counter for 2025 – PhenQ OTC Weight Loss Supplement

If you are researching the strongest over the counter weight loss supplements in 2025 -…

23 hours ago